Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
McKesson
Dow
McKinsey
Fish and Richardson
Boehringer Ingelheim
Chinese Patent Office
Johnson and Johnson

Generated: November 19, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Dalcetrapib

« Back to Dashboard

US Patents for Dalcetrapib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Dalcetrapib ➤ Try a Free Trial CETP activity inhibitors Japan Tobacco Inc. (Tokyo, JP) ➤ Try a Free Trial
Dalcetrapib ➤ Try a Free Trial Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals Aventis Pharma Deutschland GmbH (Frankfurt am Main, DE) ➤ Try a Free Trial
Dalcetrapib ➤ Try a Free Trial CETP activity inhibitor Japan Tobacco Inc. (Tokyo, JP) ➤ Try a Free Trial
Dalcetrapib ➤ Try a Free Trial Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals Aventis Pharma Deutschland GmbH (Frankfurt Am Main, DE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Dalcetrapib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Dalcetrapib Argentina 015707 2017-02-12 ➤ Try a Free Trial
Dalcetrapib Austria 338029 2017-02-12 ➤ Try a Free Trial
Dalcetrapib Australia 5781898 2017-02-12 ➤ Try a Free Trial
Dalcetrapib Australia 728979 2017-02-12 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
US Department of Justice
McKinsey
Chubb
Covington
Argus Health
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: